Roundview Capital LLC Sells 4,105 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Roundview Capital LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,334 shares of the healthcare conglomerate's stock after selling 4,105 shares during the period. Roundview Capital LLC's holdings in UnitedHealth Group were worth $10,126,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after buying an additional 319,515 shares in the last quarter. Capital International Investors lifted its position in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Norges Bank purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $6,375,744,000. Northern Trust Corp lifted its holdings in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after buying an additional 861,854 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft lowered their price objective on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Finally, JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research report on Friday, June 20th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $394.43.

UnitedHealth Group Trading Down 4.8%

Shares of NYSE UNH traded down $13.99 during mid-day trading on Thursday, hitting $278.52. The stock had a trading volume of 22,499,738 shares, compared to its average volume of 11,323,359. The firm has a market cap of $252.66 billion, a P/E ratio of 11.66, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The business has a 50 day moving average price of $301.70 and a two-hundred day moving average price of $428.82.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 3.17%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Insiders Place Their Bets

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.